Literature DB >> 28730070

Inhibition effect of curcumin on UVB-induced secretion of pro-inflammatory cytokines from corneal limbus epithelial cells.

Shih-Chun Chao1,2,3, Dan-Ning Hu4,5, Joan Roberts6, Xilun Shen4, Chia-Yi Lee1, Chan-Wei Nien1, Hung-Yu Lin1,7,8,9.   

Abstract

AIM: To study the effects of curcumin on the secretion of interleukin (IL)-6 and IL-8 by corneal limbus epithelial cells.
METHODS: Human corneal limbus epithelial cells were isolated and cultured from donor eyes and irradiated by UVB at different dosages with or without curcumin. MTT test was used for studying the effects of UVB and curcumin on the cell viability. The role of mitogen-activated protein kinase (MAPK) and nuclear factor-kappa B (NF-κB) pathways on the UVB-induced secretion of IL-6 and IL-8 were tested by addition of their inhibitors to the culture with or without UVB-radiation. Levels of various signal pathways, IL-6 and IL-8 in the cells and in the conditioned culture medium were measured by ELISA analysis.
RESULTS: UVB at 20 mJ/cm2 or less and curcumin at 20 µmol/L or less did not affect the cell viability of cultured limbus epithelial cells (P>0.05). UVB irradiation at 10 and 20 mJ/cm2 induced a significant increase of secretion of IL-6 and IL-8 and upregulated NF-κB and phosphorylated MAPK pathways of cultured limbus epithelial cells (P<0.05). Various signal pathway inhibitors, including SP600125 (JNK inhibitor), SB203580 (p38 MAPK inhibitor) and BAY11-7082 (NF-κB inhibitor) significantly decreased the UVB-induced secretion of IL-6 and IL-8 secretion (P<0.05). Curcumin at 5-20 µmol/L significantly inhibited UVB-induced secretion of IL-6 and IL-8 by limbus epithelial cells in a dose-dependent manner; while curcumin alone did not affect the secretion of IL-6 and IL-8. The upregulation of NF-κB and MAPK pathways induced by UVB treatment was significantly inhibited by curcumin, suggesting that NF-κB and MAPK pathways are involved in the inhibitory effect of curcumin on UVB-induced production of IL-6 and IL-8.
CONCLUSION: Curcumin may be a promising agent to be explored for the prevention and treatment of pterygium.

Entities:  

Keywords:  corneal limbus epithelial cells; curcumin; interleukin-6; interleukin-8; pterygium; ultraviolet-B

Year:  2017        PMID: 28730070      PMCID: PMC5515165          DOI: 10.18240/ijo.2017.06.01

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  25 in total

1.  The role of ultraviolet irradiation and heparin-binding epidermal growth factor-like growth factor in the pathogenesis of pterygium.

Authors:  Timothy M Nolan; Nick DiGirolamo; Nitin H Sachdev; Taline Hampartzoumian; Minas T Coroneo; Denis Wakefield
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

2.  Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo.

Authors:  Fusheng Yang; Giselle P Lim; Aynun N Begum; Oliver J Ubeda; Mychica R Simmons; Surendra S Ambegaokar; Pingping P Chen; Rakez Kayed; Charles G Glabe; Sally A Frautschy; Gregory M Cole
Journal:  J Biol Chem       Date:  2004-12-07       Impact factor: 5.157

3.  Regulation of collagenase, stromelysin, and urokinase-type plasminogen activator in primary pterygium body fibroblasts by inflammatory cytokines.

Authors:  A Solomon; D Q Li; S B Lee; S C Tseng
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-07       Impact factor: 4.799

4.  Corneal changes associated with chronic UV irradiation.

Authors:  H R Taylor; S K West; F S Rosenthal; B Munoz; H S Newland; E A Emmett
Journal:  Arch Ophthalmol       Date:  1989-10

5.  Pterygia pathogenesis: corneal invasion by matrix metalloproteinase expressing altered limbal epithelial basal cells.

Authors:  N Dushku; M K John; G S Schultz; T W Reid
Journal:  Arch Ophthalmol       Date:  2001-05

6.  Interleukin-1beta increases baseline expression and secretion of interleukin-6 by human uveal melanocytes in vitro via the p38 MAPK/NF-kappaB pathway.

Authors:  Dan-Ning Hu; Min Chen; David Y Zhang; Fei Ye; Steven A McCormick; Chi-Chao Chan
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-01       Impact factor: 4.799

7.  Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects.

Authors:  Marie E Egan; Marilyn Pearson; Scott A Weiner; Vanathy Rajendran; Daniel Rubin; Judith Glöckner-Pagel; Susan Canny; Kai Du; Gergely L Lukacs; Michael J Caplan
Journal:  Science       Date:  2004-04-23       Impact factor: 47.728

8.  Inhibition of the HIV-1 and HIV-2 proteases by curcumin and curcumin boron complexes.

Authors:  Z Sui; R Salto; J Li; C Craik; P R Ortiz de Montellano
Journal:  Bioorg Med Chem       Date:  1993-12       Impact factor: 3.641

Review 9.  An update on Curcuma as a functional food in the control of cancer and inflammation.

Authors:  Moshe Schaffer; Pamela M Schaffer; Gil Bar-Sela
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2015-11       Impact factor: 4.294

Review 10.  The spice for joint inflammation: anti-inflammatory role of curcumin in treating osteoarthritis.

Authors:  Kok-Yong Chin
Journal:  Drug Des Devel Ther       Date:  2016-09-20       Impact factor: 4.162

View more
  2 in total

1.  Local pro-inflammatory cytokine and nitric oxide responses are elevated in patients with pterygium.

Authors:  S Zidi; F Bediar-Boulaneb; H Belguendouz; M Belkhelfa; O Medjeber; O Laouar; C Henchiri; C Touil-Boukoffa
Journal:  Int J Immunopathol Pharmacol       Date:  2017-11-22       Impact factor: 3.219

2.  Pterygium Pathology: A Prospective Case-Control Study on Tear Film Cytokine Levels.

Authors:  Sara I Van Acker; Michel Haagdorens; Ella Roelant; Jos Rozema; Tine Possemiers; Veerle Van Gerwen; Marie-José Tassignon; Veva De Groot; Sorcha Ní Dhubhghaill; Carina Koppen; Nadia Zakaria
Journal:  Mediators Inflamm       Date:  2019-11-12       Impact factor: 4.711

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.